“On October 10, the Non-Governmental Organization (NGO) Committee on Children’s Rights at the United Nations commemorated World Mental Health Day, an official U.N. international day, with a side event on children’s psychosocial wellbeing,” Mahroo Moshari, a consultant on education and multicultural mental health issues, writes in the Huffington Post’s “Impact”…
Access to Health Services
Medicines Patent Pool Can Help Many But Has Potential Limitations For AIDS Drug Access In Middle-Income Countries
In a post on the New York Times’ “Opinionator” blog, author and journalist Tina Rosenberg writes about the Medicines Patent Pool (MPP) and describes how it can help purchase AIDS drugs for “vast numbers of people.” She also notes “its most serious potential weakness” â€“ that drug companies join because they hope that giving earlier drug access to more countries will reduce pressure for access in middle-income countries. Rosenberg highlights a recent agreement with Gilead Sciences, which “only covers very poor countries. It leaves out Egypt, China, Brazil, plus dozens of other developing countries. Current AIDS drug prices in these countries are six or seven times the price of drugs in sub-Saharan Africa. Without help from the patent pool, these countries have little hope of expanding antiretroviral coverage” (7/21).
While Cote d’Ivoire studies several options for financing public health services, its temporary policy of providing free care â€“ “which the government said was aimed to help people after the post-election crisis â€“ is causing grief for doctors and patients alike,” IRIN reports.
In her latest piece on the New York Times’ “Opinionator” blog, author and journalist Tina Rosenberg argues that the terms of Gilead’s recent agreement with the Medicines Patent Pool is “confirmation of a dangerous new trend: middle-income countries as a target market for drug makers.” “The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China â€“ middle-income countries, all â€“ as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs. This low-volume high-profit strategy might make business sense. But in terms of the war against AIDS, it means surrender,” she writes.
South Africa Could Reduce HIV-Associated Long-Term Costs, Extend Lives With Earlier Treatment, Study Says
If South Africa followed WHO recommendations for earlier therapy for people living with HIV, thousands of lives could be extended and the country would start saving money after 16 years, according to a study recently published online in PLoS One, United Press International reports.
More than 3,000 demonstrators gathered across Swaziland on Thursday for a second day of protests over the king’s handling of an economic crisis that they say is causing a shortage of medical supplies, including antiretroviral therapy (ART), the Associated Press/Washington Post reports (7/28).
In a guest post on the GlobalPost’s “Global Pulse” blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government’s “plans to launch a ‘test and treat’ program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment (ART) drugs for life.” But she adds that “[t]he growing political and economic crisis in Malawi, highlighted by the government’s use of force against peaceful demonstrators last week, could also imperil the groundbreaking expansion of Malawi’s national HIV/AIDS program.”
The Wall Street Journal and the newspaper’s “India Real Time” blog published stories on Saturday examining India’s health care system. “Indian government officials say the country’s public health infrastructure is sorely deficient, but they argue it is improving because of several initiatives underway,” the blog reports. “They acknowledge the government has spent too little â€“ around 1 percent of gross domestic product â€“ on public health. But they say India will likely double that proportion to at least 2 percent in the five-year plan beginning in 2012,” the blog notes (Anand/Sahni/Sharma, 7/30).
“Half of the 340,000 deaths of women from pregnancy-related causes each year occur in Africa, almost all in anonymity,” the New York Times writes in an article profiling several cases of women who have died during childbirth in Ugandan hospitals.
“The first field trial for a ‘lab on a chip’ accurately detected both HIV and syphilis among a Rwandan population, researchers reported Sunday” in an online report published by Nature Medicine, the Washington Post reports (Torres, 7/31).